Anxiolytic-like Effects of Polygala tenuifolia Willdenow Using the Elevated Plus Maze and Hole-board Apparatus in Mice

  • Jung, Ji-Wook (Department of Oriental Pharmaceutical Science, College of Pharmacy, Kyung Hee University) ;
  • Yoon, Byung-Hoon (Department of Oriental Pharmaceutical Science, College of Pharmacy) ;
  • Kim, Sun-Yeou (Department of Herbal Pharmacology, Graduate School of East-West Medical Science, Kyung Hee University) ;
  • Cheong, Jae-Hoon (Department of Pharmacy, Sahmyook University) ;
  • Ryu, Jong-Hoon (Department of Oriental Pharmaceutical Science, College of Pharmacy, Kyung Hee University)
  • Published : 2005.06.01

Abstract

The purpose of this study was to characterize the putative anxiolytic-like effects of the aqueous extract of the root of Polygala tenuifolia ( AEPT) using an elevated plus maze (EPM) and hole-board apparatus in mice. The AFPT was orally administered at 50, 100, 200 or 400 mg/kg to ICR mice, 1 h before the behavioral evaluation in the EPM respectively. Control mice were treated with an equal volume of saline, and positive control mice with buspirone (2 mg/kg). Single treatments of the AEPT significantly increased the percentage of time spent and arm entries into the open arms of the EPM vedrsus saline controls (P<0.05). Moreover, there were no changes in the locomotor activity and myorelaxant effects in any group compared with the saline controls. In the hole-board test,single treatments of the AEPT (200 and 400 mg/kg) significantly increased the number of headdips versus saline controls (P<0.05). In addition, the anxiolytic-like effects of the AEPT were blocked by WAY 100635(0.3mg/kg, I.p), a5-$HT_{1A}$ receptor antagonist not by flumazenil, a $GABA_{A}$ antagonist. These results indicate that P. tenuifolia is an effective anxiolytic agent, andsuggest that the anxiolytic-like effects of P. tenuifolia is mediated via the serotonergic nervous system.

Keywords

References

  1. Bonetti, E. P., Pieri, L., Cumin, R., Schaffner, R., Pieri, M., Gamzu, E.R., Muller, R.K.M., Haefely, W. (1982). Benzodiazepine antagonist Ro 15-1788: neurological and behavioral effects. Psychopharmacol. 78, 8-18 https://doi.org/10.1007/BF00470579
  2. Carlini, E. A. (2003). Plants and the central nervous system. Pharmacol. Biochem. Behav. 75, 501-512 https://doi.org/10.1016/S0091-3057(03)00112-6
  3. Chen, Y. L., Hsieh, C. L., Wu, P. H. B., Lin, J. G. (2004). Effect of Poly gala tenuifolia root on behavioral disorders by lesioning nucleus basalis magnocellularis in rat. J Ethnopharmacol. 95, 47-55 https://doi.org/10.1016/j.jep.2004.06.015
  4. Chung, I. W., Kim, Y. S., Ahn, J. S., Lee, H. S., Chen, G., Manji, H. K., Potter, W. Z., Pickar, D. (1995). Pharmacologic profile of natural products used to treat psychotic illnesses. Psychopharmacol. Bull. 31, 139-145
  5. Chung, I. W., Moore, N. A., Oh, W. K., O'Neill, M. F., Ahn, J. S., Park, J. B., Kang, U. G., Kim, Y. S. (2002). Behavioural pharmacology of polygalasaponins indicates potential antipsychotic efficacy. Pharmacol. Bioche. Behav. 71, 191-195 https://doi.org/10.1016/S0091-3057(01)00648-7
  6. Dawson, G. R., Tricklebank, M.D. (1995). Use of the elevated plus maze in the search for novel anxiolytic agents. Trends. Pharmacol. Sci. 16, 33-36 https://doi.org/10.1016/S0165-6147(00)88973-7
  7. Ikeya, Y., Sugama, K., Okada, M., Mitsuhashi, H. (1991). Two xanthones from polygala tenuifolia. Phytochemistry 30, 2061-2065 https://doi.org/10.1016/0031-9422(91)85067-A
  8. Kataoka, Y., Shibata, K., Miyazaki, A., Inoue, Y., Tominaga, K., Koizumi, S., Ueki, S., Niwa, M. (1991). Involvement of the dorsal hippocampus in mediation of the antianxiety action of tandospirone, a $5-hydroxytryptamine_{1A}$ agonistic anxiolytic, Neuropharmacology 30 475-480 https://doi.org/10.1016/0028-3908(91)90009-Z
  9. Kawashima, K., Miyako, D., Ishino, Y., Makino, T., Saito, K.I., Kano, Y. (2004). Anti-stress effects of 3,4,5-trimethoxycinnamic acid, an active constituent of roots of Polygala tenuifolia (Onji). Biol. Pharm. Bull. 27, 1317-1319 https://doi.org/10.1248/bpb.27.1317
  10. Lader, M., Morton, S. (1991). Benzodiazepine problems. Br. J Addict., 86, 823-828 https://doi.org/10.1111/j.1360-0443.1991.tb01831.x
  11. Lister, R. G. (1987). The use of a plus-maze to measure anxiety in the mouse. Psychopharmacology 92, 180-185
  12. Nikaido, T., Ohmoto, T., Sankawa, U., Hamanaka, T., Totsuka, K. (1982). Inhibition of cyclic AMP phosphodiesterase by flavonoids. Planta Med. 46. 162-166 https://doi.org/10.1055/s-2007-970043
  13. Park, C. H., Choi, S. H., Koo, J. W., Seo, J. H., Kim, H. S., Jeong, S. J., Suh., Y. H. (2002). Novel cognitive improving and neuroprotective activities of Polygala tenuifolia Willdenow extract, BT-ll. J Neurosci. Res. 70, 484-492 https://doi.org/10.1002/jnr.10429
  14. Pellow, S., File, S. E. (1986). Anxiolytic and anxiogenic drug effects on exploratory activity in an elevated plus-maze: a novel test of anxiety in the rat. Pharmacol. Biochem. Behav. 24, 525-529 https://doi.org/10.1016/0091-3057(86)90552-6
  15. Remy, S. M., Schreiber, R., Dalmus, M., De Vry, J. (1996). Somatodendritic $5-HT_{1A}$ receptors are critically involved in the anxiolytic effects of 8-OH-DPAT. Psychopharmacology 125, 89-91 https://doi.org/10.1007/BF02247397
  16. Sakuma, S., Shoji., J. (1981). Studies on the constituents of the root of Polygala tenuifolia Willdenow. Chem. Pharm. Bull. 29, 2431-2441 https://doi.org/10.1248/cpb.29.2431
  17. Schreiber, R., De Vry, J. (1993). Neuronal circuits involved in the anxiolytic effects of the $5-HT_{1A}$ receptor agonists 8-OHDPAT ipsapirone and buspirone in the rat. Eur. J Pharmacol. 249, 341-351 https://doi.org/10.1016/0014-2999(93)90531-L
  18. Shin, E. J., Oh, K. W., Kim, K. W., Kwon, Y. S., Jhoo, J. H., Jhoo, W. K., Cha, J. Y., Lim, Y. K., Kim, I. S., Kim, H. C. (2004). Attenuation of cocaine-induced conditioned place preference by Polygala tenuifolia root extract. Life Sci. 75, 2751-2764 https://doi.org/10.1016/j.lfs.2004.04.045
  19. Takeda, H., Tsuji, M., Matsumiya, T. (1998). Changes in headdipping behavior in the hole-board test reflect the anxiogenic and/or anxiolytic state in mice. Eur. J Pharmacol. 350, 21-29 https://doi.org/10.1016/S0014-2999(98)00223-4